Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 4/20 | 0.54 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.47 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.47 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.47 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.46 |
| ▸ | TYMS | P04818 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclohexylamine SCHEMBL30763312 | 1.00 | F2 (0.54) | F2PRSS1PRSS2PRSS3NLRP3 | |
| Cyclohexylamine SCHEMBL29197249 | 1.00 | F2 (0.54) | F2PRSS1PRSS2PRSS3NLRP3 | |
| SCHEMBL29683331 | 0.88 | F2 (0.55) | F2PRSS1PRSS2PRSS3CA2 | |
| SCHEMBL867347 | 0.88 | F2 (0.55) | F2PRSS1PRSS2PRSS3CA2 | |
| SCHEMBL867346 | 0.88 | F2 (0.55) | F2PRSS1PRSS2PRSS3CA2 | |
| Cyclohexylamine SCHEMBL30852798 | 0.85 | SLC1A3 (0.54) | F2 | |
| Cyclohexylamine SCHEMBL1169027 | 0.84 | F2 (0.55) | F2 | |
| Cyclohexylamine SCHEMBL1169023 | 0.84 | F2 (0.55) | F2 | |
| Cyclohexylamine SCHEMBL25313860 | 0.83 | F2 (0.54) | F2TYMS | |
| Cyclohexylamine SCHEMBL6239195 | 0.83 | F2 (0.66) | F2TYMS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250277200-A1 | ENGINEERED CPN1 CONSTRUCTS AND VARIANTS | VERTEX PHARMACEUTICALS INCORPORATED | 2025-09-04 | — | — | US | disclosed |
| CN-117440822-A | Engineered CPN1 constructs and variants | 弗特克斯药品有限公司 | 2024-01-23 | — | — | CN | disclosed |
| EP-4284416-A1 | ENGINEERED CPN1 CONSTRUCTS AND VARIANTS | Vertex Pharmaceuticals Incorporated (US) | 2023-12-06 | — | — | EP | disclosed |
| US-20190300824-A1 | BACTERIAL SPORE COMPOSITIONS FOR INDUSTRIAL USES | ENVERA LIC, LLC (US) | 2019-10-03 | — | — | US | disclosed |
| US-10308909-B2 | Dried spore germinative compound mixtures | ENVERA LIC, LLC (US) | 2019-06-04 | — | — | US | disclosed |
| EP-2954041-B1 | DRIED SPORE GERMINATIVE COMPOUND MIXTURES | ENVERA LLC (US) | 2018-08-29 | — | — | EP | disclosed |
| US-9932543-B2 | Bacterial spore compositions for industrial uses | ENVERA, LLC (US) | 2018-04-03 | — | — | US | disclosed |
| US-20160362654-A1 | DRIED SPORE GERMINATIVE COMPOUND MIXTURES | ENVERA, LLC (US) | 2016-12-15 | — | — | US | disclosed |
| US-9447376-B2 | Dried spore germinative compound mixtures | ENVERA, LLC (US) | 2016-09-20 | — | — | US | disclosed |
| US-20160040119-A1 | BACTERIAL SPORE COMPOSITIONS FOR INDUSTRIAL USES | ENVERA, LLC (US) | 2016-02-11 | — | — | US | disclosed |
| US-20160037781-A1 | BACTERIAL SPORE COMPOSITIONS FOR INDUSTRIAL USES | ENVERA, LLC (US) | 2016-02-11 | — | — | US | disclosed |
| EP-2954041-A1 | DRIED SPORE GERMINATIVE COMPOUND MIXTURES | Envera LLC (US) | 2015-12-16 | — | — | EP | disclosed |
| WO-2014124120-A1 | DRIED SPORE GERMINATIVE COMPOUND MIXTURES | ENVERA, LLC (US) | 2014-08-14 | — | — | WO | disclosed |
| US-20140220662-A1 | DRIED SPORE GERMINATIVE COMPOUND MIXTURES | ENVERA, LLC (US) | 2014-08-07 | — | — | US | disclosed |